Hyperbaric (HYRB.OB) - Company Overview . is this too good an idea right now? Any comments.
HBS TECHNOLOGY -
AN OVERVIEW
With over a decade of scientific research experience in the preservation of biologic material behind it, HyperBaric Systems was formed recently to complete the development of and commercialize the preservation technology for platelets, organs, heart valves and other tissues. We chose to address platelet preservation first because of the impact it would have on blood banking worldwide, economically and medically. The preservation of blood platelets involves a nontoxic proprietary solution and process to suppress bacterial growth while maintaining platelet functionality. Our initial goal is to deliver a practical, commercially reproducible method to preserve platelets for up to 7-9 days of shelf life under refrigeration. We are then planning to develop methods to store platelets for 14 days and organs from hours to days, under sub-zero conditions using a special container, solutions and process.
Preliminary preservation tests have been conducted for platelets and animal kidneys. We are currently conducting further tests on platelets to determine the best preservation conditions and exact limits of platelet functionality, which will then be the basis for FDA and CE-Mark testing and submissions. While further testing and development work is necessary, and FDA testing and certification is required prior to distributing the platelet preservation system for commercial use, our goal is to preserve platelets for 7-9 days under refrigeration and 14 days at sub-zero temperatures.
Organ preservation results also look promising using animal's kidneys. We have recently started testing our new organ preservation solution on dog's kidneys at an institute in Mexico. Our first goal is to develop and introduce a solution that can be used in the conventional way - under refrigeration. As with platelets, we then plan to extend the shelf life further by storing the organs at sub-zero temperatures using a proprietary set of solutions, a lightweight container and the protocols for using the system. The preservation process currently requires no toxic solutions that remain with the organ.
I checked the hompage, which is really well-done at:
hyperbaricsystems.com
I have worked in medical settings and blood platelet use and preservation in the US and world blood supplies is a critical issue, especially in light of the expense it takes to screen and ensure a safe donor blood supply in light of AIDS, Hepatitis Virus, etc.
If Hyperbaric technology becomes accepted by the FDA as a medical device after clincial studies are concluded, then this company will be a mainstay at all major modern hospitals throught the world. Personally, i think it is way undervalued if this is the case.
Just some thoughts,
Jack |
